Transport target expression, a biomarker of brain shuttle fusion drug uptake, shows minimal influence of brain region, disease state, gender, and age, yet reveals significant individual variation
Together, the current and planned studies can help to inform the development of personalized approaches to selecting patients for specific fusion drug treatments.
Authors
- Sanjid Shahriar
- Ana R. Santa‐Maria
Institutions
- Harvard University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_103829
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00